| pubmed-article:11438026 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11438026 | lifeskim:mentions | umls-concept:C0369335 | lld:lifeskim |
| pubmed-article:11438026 | lifeskim:mentions | umls-concept:C0005768 | lld:lifeskim |
| pubmed-article:11438026 | lifeskim:mentions | umls-concept:C0005794 | lld:lifeskim |
| pubmed-article:11438026 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:11438026 | lifeskim:mentions | umls-concept:C0032520 | lld:lifeskim |
| pubmed-article:11438026 | lifeskim:mentions | umls-concept:C0332257 | lld:lifeskim |
| pubmed-article:11438026 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11438026 | pubmed:dateCreated | 2001-7-4 | lld:pubmed |
| pubmed-article:11438026 | pubmed:abstractText | To assess the cost and effectiveness of adding a system of polymerase chain reaction (PCR) testing to the current enzyme-linked immunosorbent assay (ELISA) screening for hepatitis C virus (HCV) in blood donations. | lld:pubmed |
| pubmed-article:11438026 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11438026 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11438026 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11438026 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11438026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11438026 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11438026 | pubmed:month | May | lld:pubmed |
| pubmed-article:11438026 | pubmed:issn | 0042-9007 | lld:pubmed |
| pubmed-article:11438026 | pubmed:author | pubmed-author:CostagliolaDD | lld:pubmed |
| pubmed-article:11438026 | pubmed:author | pubmed-author:Durand-Zalesk... | lld:pubmed |
| pubmed-article:11438026 | pubmed:author | pubmed-author:RotilyMM | lld:pubmed |
| pubmed-article:11438026 | pubmed:author | pubmed-author:LoubièreSS | lld:pubmed |
| pubmed-article:11438026 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11438026 | pubmed:volume | 80 | lld:pubmed |
| pubmed-article:11438026 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11438026 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11438026 | pubmed:pagination | 199-204 | lld:pubmed |
| pubmed-article:11438026 | pubmed:dateRevised | 2011-1-11 | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:meshHeading | pubmed-meshheading:11438026... | lld:pubmed |
| pubmed-article:11438026 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11438026 | pubmed:articleTitle | Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective. | lld:pubmed |
| pubmed-article:11438026 | pubmed:affiliation | Institut National de la Santé et de la Recherche Médicale INSERM U379, Marseille, France. loubiere@marseille.inserm.fr | lld:pubmed |
| pubmed-article:11438026 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11438026 | lld:pubmed |
